- Home
- WSHP vs HYFT Comparison
WSHP vs HYFT Comparison
Compare WSHP & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSHP | HYFT |
|---|---|---|
| Founded | 2021 | 1983 |
| Country | British Virgin Islands | United States |
| Employees | 20 | 102 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.8M | 66.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WSHP | HYFT |
|---|---|---|
| Price | $5.35 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 64.7K | ★ 255.3K |
| Earning Date | 01-01-0001 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.33 | $0.99 |
| 52 Week High | $250.00 | $3.00 |
Technical Indicators
Market Signals| Indicator | WSHP | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 42.07 |
| Support Level | N/A | $1.17 |
| Resistance Level | $7.50 | $1.44 |
| Average True Range (ATR) | 0.54 | 0.11 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 26.71 | 45.57 |
Price Performance
Historical ComparisonAbout WSHP WeShop Holdings Limited Class A Ordinary Shares
WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.
About HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.